Literature DB >> 10220386

Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.

M Kobayashi1, S Nagata, T Iwasaki, K Yanagihara, I Saitoh, Y Karouji, S Ihara, Y Fukui.   

Abstract

Signet ring cell carcinoma is a malignant type of poorly differentiated adenocarcinomas in stomach, which is characterized by the occasional presence of signet ring-like cancer cells. We found that expression of constitutively active phosphatidylinositol 3-kinase (PI 3-kinase) in well differentiated adenocarcinoma cell lines induced the loss of cell-cell contact and some of the cells changed their shapes to signet ring cell-like, characterized by appearance of mucus droplets in the cytoplasm with well developed endplasmic reticulum and Golgi complexes. The active PI 3-kinase-expressing cells formed poorly differentiated tumors in nude mice, which were clearly different from those of the original cell lines. The PI 3-kinase activities detected in anti-phosphotyrosine immunoprecipitates were higher in several signet ring cell carcinoma-derived cell lines than in other adenocarcinoma cell lines. In addition, PI 3-kinase was found to be associated with a 200-kDa protein phosphorylated in tyrosine in 4 of 6 signet ring cells but not in other cell lines, suggesting that PI 3-kinase is possibly activated in these cells by binding to the 200-kDa protein. The 200-kDa protein-PI 3-kinase complex was exclusively fractionated in the membrane fractions. The specific activity of the PI 3-kinase immunoprecipitated with anti-phosphotyrosine antibody was approximately 3-fold higher than that with anti-PI 3-kinase antibody. These results suggest that PI 3-kinase in signet ring cell carcinoma is recruited to the membrane and activated by the binding to the 200-kDa protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220386      PMCID: PMC21784          DOI: 10.1073/pnas.96.9.4874

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Morphometric and colorimetric analyses of human tumor cell line growth and drug sensitivity in soft agar culture.

Authors:  M C Alley; C M Pacula-Cox; M L Hursey; L R Rubinstein; M R Boyd
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

Review 2.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  Primary signet ring cell adenocarcinoma of the bladder with elevated serum carbohydrate antigens 19-9 and 50.

Authors:  T Ohnita; H Sakai; M Matsuo; H Hisamatsu; I Shimokawa; Y Saito
Journal:  J Urol       Date:  1998-05       Impact factor: 7.450

4.  Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line.

Authors:  E M Eves; W Xiong; A Bellacosa; S G Kennedy; P N Tsichlis; M R Rosner; N Hay
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

5.  The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase.

Authors:  L Varticovski; B Druker; D Morrison; L Cantley; T Roberts
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

6.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

7.  Phosphatidylinositol-3 kinase is activated in v-src, v-yes, and v-fps transformed chicken embryo fibroblasts.

Authors:  Y Fukui; A R Saltiel; H Hanafusa
Journal:  Oncogene       Date:  1991-03       Impact factor: 9.867

8.  Insulin-dependent formation of a complex containing an 85-kDa subunit of phosphatidylinositol 3-kinase and tyrosine-phosphorylated insulin receptor substrate 1.

Authors:  K Yonezawa; H Ueda; K Hara; K Nishida; A Ando; A Chavanieu; H Matsuba; K Shii; K Yokono; Y Fukui
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

9.  Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation.

Authors:  A Klippel; M A Escobedo; M S Wachowicz; G Apell; T W Brown; M A Giedlin; W M Kavanaugh; L T Williams
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

10.  Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells.

Authors:  K Yanagihara; M Tsumuraya
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

View more
  21 in total

1.  Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins.

Authors:  K Nishigaki; C Hanson; T Ohashi; D Thompson; K Muszynski; S Ruscetti
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues.

Authors:  Matthias Steinert; Manja Wobus; Carsten Boltze; Alexander Schütz; Mandy Wahlbuhl; Jörg Hamann; Gabriela Aust
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?

Authors:  Hilda Wong; Thomas Yau
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 4.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 5.  Current advances of targeting HGF/c-Met pathway in gastric cancer.

Authors:  Aristomenis Anestis; Ilianna Zoi; Michalis V Karamouzis
Journal:  Ann Transl Med       Date:  2018-06

6.  Adenocarcinoma coexisting with signet ring cell carcinoma in nonampullary duodenum.

Authors:  Tae Hoon Lee; Joon Ho Wang; Yun Hyeong Lee; Soon Young Ko; Chung Hyeon Ma; Bohng Hee Kim
Journal:  Turk J Gastroenterol       Date:  2020-03       Impact factor: 1.852

7.  Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.

Authors:  Sara M Johnson; Pat Gulhati; Bill A Rampy; Yimei Han; Piotr G Rychahou; Hung Q Doan; Heidi L Weiss; B Mark Evers
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

8.  Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.

Authors:  Ming Yu; William M Grady
Journal:  Therap Adv Gastroenterol       Date:  2012-09       Impact factor: 4.409

9.  A phosphatidylinositol 3-kinase docking site in the cytoplasmic tail of the Jaagsiekte sheep retrovirus transmembrane protein is essential for envelope-induced transformation of NIH 3T3 cells.

Authors:  M Palmarini; N Maeda; C Murgia; C De-Fraja; A Hofacre; H Fan
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase.

Authors:  Frauke Leenders; Kristin Möpert; Anett Schmiedeknecht; Ansgar Santel; Frank Czauderna; Manuela Aleku; Silke Penschuck; Sibylle Dames; Maria Sternberger; Thomas Röhl; Axel Wellmann; Wolfgang Arnold; Klaus Giese; Jörg Kaufmann; Anke Klippel
Journal:  EMBO J       Date:  2004-07-29       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.